SCHEMBL20525580

SCHEMBL20525580

COc1ccc2c(Oc3ccc(NC(=O)C(=O)NCC(c4ccccc4)N(C)C)cc3F)ccnc2c1OC

nearest known ligand 0.51

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.51
KDR P35968 3/20 0.45
OPRD1 P41143 1/20 0.44
AXL P30530 1/20 0.42
IGF1R P08069 1/20 0.41
SLC6A5 Q9Y345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525820 0.90 MET (0.51) METKDRIGF1R
SCHEMBL20525707 0.89 MET (0.49) METKDROPRD1IGF1R
SCHEMBL371808 0.88 MET (0.67) METKDRAXL
SCHEMBL20525633 0.85 MET (0.52) METKDRAXL
SCHEMBL20525675 0.84 POLB (0.58) METKDRAXL
SCHEMBL20525748 0.83 MET (0.49) METKDRIGF1R
SCHEMBL20525668 0.80 MET (0.52) METKDRIGF1R
SCHEMBL20525731 0.80 MET (0.49) METKDRAXL
SCHEMBL29693638 0.79 MET (0.63) METKDR
SCHEMBL371714 0.79 MET (0.63) METKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed